Biopharmaceutical Analysis & Statistics, March 2015

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

1-30 of about 1 800 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Hospitality, Hospitality, Tourism, Tourism, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World, Europe
PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : Europe
Global Markets for Research Antibodies

Global Markets for Research Antibodies

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound ...

  • Industries : Biopharmaceutical
  • Countries : World
Biosimilars: Global Markets

Biosimilars: Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014. The market is expected to reach nearly $4.0 billion by 2019, with a compound annual growth ...

  • Industries : Biopharmaceutical
  • Countries : World
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...

  • Industries : Biopharmaceutical, Drug and Medication, Pathology, Pharmaceutical
  • Countries : World
Antibody Drugs: Technologies and Global Markets

Antibody Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting ...

  • Industries : Biopharmaceutical
  • Countries : World
Biologic Therapeutic Drugs: Technologies and Global Markets

Biologic Therapeutic Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global biologics market totaled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of ...

  • Industries : Biopharmaceutical
  • Countries : World
Analysis of the Global Vaccines Delivery Market : Innovative Technologies and Future Trends for Stakeholders

Analysis of the Global Vaccines Delivery Market : Innovative Technologies and Future Trends for Stakeholders

  • $ 6 500
  • Industry report
  • March 2015
  • by Frost & Sullivan

Methodology The analysis in this research service is based on the following: •Information collected through discussions with market participants. •Information from secondary pharmaceutical companies, ...

  • Industries : Drug Delivery Technology, Biopharmaceutical, Drug and Medication
  • Countries : World
Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders

Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders

  • $ 6 450
  • Industry report
  • February 2015
  • by Firstword Pharma

Based on survey results from 150 rheumatologists, dermatologists, and gastroenterologists in UK, France, Germany, Spain and Italy, Medical Affairs Reputations (EU5): Biosimilar mAbs in Inflammatory Disorders ...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom, France, Germany, Spain, Italy
Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 6 000
  • Industry report
  • March 2015
  • by Feedback Business Consulting

This report provides an insight into the Opportunity in the Indian Biopharmaceuticals current market scenario, structure and practices. In depth market scenario includes; - Indian Biopharmaceuticals Market ...

  • Industries : Biopharmaceutical
  • Countries : India
PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical
  • Countries : United States
PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : Japan, Asia
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : Australia, Oceania
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : China, Asia
PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : India, Asia
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • $ 4 995
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
World Enzyme-Linked Immunosorbent Assay (ELISA)  Industry

World Enzyme-Linked Immunosorbent Assay (ELISA) Industry

  • $ 4 950
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousands by the following Product Segments: ELISA Development Sets and Antibody Pairs, and ELISA Kits. The ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe
Foot and Mouth Disease (FMD) Vaccines Market (By Types: Conventional Vaccines and Emergency Vaccines, and By Applications: Cattle, Pigs, Sheep and Goats and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Foot and Mouth Disease (FMD) Vaccines Market (By Types: Conventional Vaccines and Emergency Vaccines, and By Applications: Cattle, Pigs, Sheep and Goats and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • $ 4 795
  • Industry report
  • January 2015
  • by Transparency Market Research

Foot-and-mouth disease (FMD) is an infection caused by aphthovirus belonging to the family Picornaviridae. FMD is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories ...

  • Industries : Biopharmaceutical, Drug and Medication
  • Countries : World
Biocatalysis & Biocatalysts Market By Type, Application, And Geography - Forecast Till 2019

Biocatalysis & Biocatalysts Market By Type, Application, And Geography - Forecast Till 2019

  • $ 4 650
  • Industry report
  • February 2015
  • by MarketsandMarkets

The biocatalysts market was estimated around 81 kilo tons in 2013, with the high share of around 70% held by North America and Europe together. The global biocatalysts market by volume is projected to ...

  • Industries : Biotechnology, Chemical, Chemical, Manufacturing, Chemical and Material
  • Countries : Europe, World, North America, Asia
Molecular Weight Marker Market by Products, Type, Application, & End User - Global Forecast to 2019

Molecular Weight Marker Market by Products, Type, Application, & End User - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • February 2015
  • by MarketsandMarkets

The global molecular weight markers market comprises of DNA, Protein and RNA markers. The molecular weight markers market is further divided on the basis of type and size. The molecular weight markers ...

  • Industries : Office Supply and Stationery, Office Goods, Biotechnology, Genomics
  • Countries : World
Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019

Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • February 2015
  • by MarketsandMarkets

The global molecular weight markers market comprises of DNA, Protein and RNA markers. The molecular weight markers market is further divided on the basis of type and size. The molecular weight markers ...

  • Industries : Office Supply and Stationery, Office Goods, Biotechnology, Genomics
  • Countries : World
Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019

Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019

  • $ 4 650
  • Industry report
  • January 2015
  • by MarketsandMarkets

The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease ...

  • Industries : Biopharmaceutical, Drug and Medication
  • Countries : Asia, Europe, North America
Enzymes  Markets in China

Enzymes Markets in China

  • $ 4 000
  • Industry report
  • March 2015
  • by Asia Market Information & Development Company

China's demand for Enzymes has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : China
New Phase of Mab biosimilar knocks the door  Biosimilar Oppurtunities In Japan

New Phase of Mab biosimilar knocks the door Biosimilar Oppurtunities In Japan

  • $ 4 000
  • Industry report
  • February 2015
  • by MP Advisors

The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : Japan
New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

  • $ 4 000
  • Industry report
  • January 2015
  • by MP Advisors

The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : Japan
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015

Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015

  • $ 3 500
  • Industry report
  • March 2015
  • by Delve Insight

Summary: DelveInsight’s Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain. The Report provides the marketed and pipeline ...

  • Industries : Biopharmaceutical
  • Countries : World
Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : World
Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical
  • Countries : World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.